IC-MPGN market growth driven by rising prevalence, emerging premium-priced therapies, and off-label treatments addressing chronic immune-related kidney damage in adult populations.Dublin, Dec. 12, ...
We are pleased to share the reappointment of Dr. Michelle Hladunewich as Chief of the Department of Medicine at Sunnybrook ...